Novartis AG;Beth Israel Deaconess Medical Center, Inc.
发明人:
Rosenzweig, Anthony,Roh, Jason D.,Glass, David J.
申请号：
AU2018240117
公开号：
AU2018240117A1
申请日:
2018.03.20
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The disclosure relates to novel uses and methods for preventing and/or treating heart disease, which employ a therapeutically effective amount of an ActRII receptor antagonist, e.g., an ActRII receptor binding molecule, e.g., an ActRII receptor antibody, such as the bimagrumab antibody.
